WNS (Holdings) Limited (NYSE: WNS), a leading provider of global digital-led Business Process Management (BPM) solutions, today announced that for the second consecutive year it has been recognized as a ‘Leader’ in NelsonHall’s 2024 NEAT Vendor Evaluation for Healthcare Payer Operations Transformation in the overall market segment.

WNS’ ability to deliver technology-driven transformation across Healthcare payer operations including clinical summarization and care management has been highlighted as a key strength. The company’s clinical summarization platform, powered by Gen AI, is able to quickly and efficiently process large volumes of medical information to streamline prior authorization and reduce fraud, waste, and abuse (FWA). The Gen AI care management platform supports value-based care models which improve patient satisfaction, reduce medical cost, and drive health outcomes. WNS’ domain capabilities, advanced analytics expertise, and outcome-based pricing models have also been cited as key differentiators.

“Expanding AI and Gen AI capabilities are creating new growth opportunities in the payer market. WNS is proactively addressing this trend by creating solutions which combine domain, data, and technology to improve outcomes for all stakeholders across the healthcare value chain,” said Keshav R. Murugesh, Group CEO, WNS.

Bilal Chaudhry, Principal Healthcare & Insurance Analyst, NelsonHall, said: “WNS was identified as a Leader in the Healthcare Payer Operations Transformation NEAT for its ability to provide substantial benefits to clients with its innovative approach and continued investment in new technologies. This includes integration of Gen AI capabilities to enhance healthcare operations and its ­overall strategy that promotes an advisor-led approach to building solutions.”

WNS serves some of the largest Health Insurance companies in the US. WNS’ deep clinical expertise, technology-enabled digital solutions, and advanced analytics capabilities enable clients to drive digital transformation and improve healthcare outcomes. WNS’ utilization management, care management, and payment integrity programs provide significant savings and improve clinical appropriateness. The company’s administrative services reduce operating costs by boosting digital adoption across provider and member experiences, data management, and claims processing.

About NelsonHall

NelsonHall is the leading global analyst firm dedicated to helping organizations understand the ‘art of the possible’ in digital operations’ transformation. With analysts in the U.S., U.K., Continental Europe, and India, NelsonHall provides buy-side organizations with detailed, critical information on markets and vendors (including NEAT assessments) that helps them make fast and highly informed sourcing decisions. For vendors, NelsonHall provides deep knowledge of market dynamics and user requirements to help them hone their go-to-market strategies. NelsonHall’s analysis is based on rigorous, primary research, and is widely respected for the quality and depth of its insight.

About WNS

WNS (Holdings) Limited (NYSE: WNS) is a leading Business Process Management (BPM) company. WNS combines deep industry knowledge with technology, analytics, and process expertise to co-create innovative, digitally led transformational solutions with over 600 clients across various industries. WNS delivers an entire spectrum of BPM solutions including industry-specific offerings, customer experience services, finance and accounting, human resources, procurement, and research and analytics to re-imagine the digital future of businesses. As of June 30, 2024, WNS had 60,513 professionals across 64 delivery centers worldwide including facilities in Canada, China, Costa Rica, India, Malaysia, the Philippines, Poland, Romania, South Africa, Sri Lanka, Turkey, the United Kingdom, and the United States.

For more information, visit www.wns.com or follow us on Facebook, Twitter, LinkedIn, and Instagram.

Safe Harbor Provision

This document includes information which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events. Factors that could cause actual results to differ materially from those expressed or implied are discussed in our most recent Form 20-F and other filings with the Securities and Exchange Commission. WNS undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Investors: David Mackey EVP – Finance & Head of Investor Relations WNS (Holdings) Limited +1 (646) 908-2615 david.mackey@wns.com

Media: Archana Raghuram EVP & Global Head – Marketing & Communications WNS (Holdings) Limited +91 (22) 4095 2397 archana.raghuram@wns.com; pr@wns.com

Grafico Azioni WNS (NYSE:WNS)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di WNS
Grafico Azioni WNS (NYSE:WNS)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di WNS